Patent details

EP3526223 Title: METHOD FOR ISOLATION AND PURIFICATION OF NALTREXONE

Basic Information

Publication number:
EP3526223
PCT Application Number:
SK2017000008
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177876711
PCT Publication Number:
WO2018070943
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD FOR ISOLATION AND PURIFICATION OF NALTREXONE
French Title of Invention:
PROCÉDÉ D'ISOLEMENT ET DE PURIFICATION DU NALTREXONE
German Title of Invention:
VERFAHREN ZUR ISOLATION UND REINIGUNG VON NALTREXON
SPC Number:

Dates

Filing date:
06/10/2017
Grant date:
17/03/2021
EP Publication Date:
21/08/2019
PCT Publication Date:
19/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/03/2021
EP B1 Publication Date:
17/03/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/10/2021
Expiration date:
06/10/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/03/2021
 
 

Name:
Saneca Pharmaceuticals a.s.
Address:
Nitrianska 100, 920 27 Hlohovec, Slovakia (SK)

Inventor

1

Name:
HERCEK, Richard
Address:
Slovakia (SK)

2

Name:
GASPAR, Ján
Address:
Slovakia (SK)

3

Name:
VANDÁK, Dusan
Address:
Slovakia (SK)

4

Name:
PALÍK, Miroslav
Address:
Slovakia (SK)

5

Name:
KAVALA, Miroslav
Address:
Slovakia (SK)

Priority

Priority Number:
50282016
Priority Date:
11/10/2016
Priority Country:
Slovakia (SK)

Classification

IPC classification:
A61K 9/00; A61K 47/08; A61P 25/36; C07D 489/08;

Publication

European Patent Bulletin

Issue number:
202111
Publication date:
17/03/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages